|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 248.08 USD | -0.73% |
|
-4.98% | +8.57% |
| Jul. 10 | Biopharma Pricing Power Seen as Key Swing Factor for Q2 Earnings, BofA Says | MT |
| Jul. 10 | BofA Securities Adjusts AbbVie Price Target to $276 From $234 | MT |
Official Publications
| May. 07 | SEC Filing 10Q-1 | CO |
| Apr. 28 | 1st quarter results | CO |
| Apr. 28 | SEC Filing 8K | CO |
| Mar. 22 | Proxy Statments | CO |
| Feb. 19 | SEC Filing 10K | CO |
| Feb. 03 | Annual results | CO |
| Feb. 03 | SEC Filing 8K | CO |
| 25-10-30 | 3rd quarter results | CO |
| 25-10-30 | SEC Filing 10Q-3 | CO |
| 25-10-30 | SEC Filing 8K | CO |
| 25-10-02 | SEC Filing 8K | CO |
| 25-09-10 | SEC Filing 8K | CO |
| 25-08-03 | SEC Filing 10Q-2 | CO |
| 25-07-30 | 1st-half-year results | CO |
| 25-07-30 | SEC Filing 8K | CO |
| 25-05-08 | SEC Filing 10Q-1 | CO |
| 25-05-07 | Minutes of the general assembly | CO |
| 25-04-24 | 1st quarter results | CO |
| 25-04-24 | SEC Filing 8K | CO |
| 25-04-02 | SEC Filing 8K | CO |
| 25-03-23 | Proxy Statments | CO |
| 25-02-25 | SEC Filing 8K | CO |
| 25-02-18 | SEC Filing 8K | CO |
| 25-02-13 | SEC Filing 8K | CO |
| 25-02-13 | SEC Filing 10K | CO |
- Stock Market
- Stocks
- ABBV Stock
- News AbbVie Inc.
- Official Publications
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
